These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10633467)

  • 41. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
    Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasound in clinical setting of secondary hyperparathyroidism.
    Meola M; Petrucci I; Cupisti A
    J Nephrol; 2013; 26(5):848-55. PubMed ID: 23042437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
    Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrasound-based scores as predictors for nodular hyperplasia in patients with secondary hyperparathyroidism: a prospective validation study.
    Gwiasda J; Kaltenborn A; Müller JA; Serttas M; Scheumann GW; Schrem H; Jäger MD
    Langenbecks Arch Surg; 2017 Mar; 402(2):295-301. PubMed ID: 28054194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.
    Goto S; Komaba H; Fukagawa M
    NDT Plus; 2008 Aug; 1(Suppl 3):iii2-iii8. PubMed ID: 25983967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.
    Fletcher S; Kanagasundaram NS; Rayner HC; Irving HC; Fowler RC; Brownjohn AM; Turney JH; Will EJ; Davison AM
    Nephrol Dial Transplant; 1998 Dec; 13(12):3111-7. PubMed ID: 9870475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
    Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
    BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical management of secondary hyperparathyroidism in uremia.
    Tominaga Y
    Am J Med Sci; 1999 Jun; 317(6):390-7. PubMed ID: 10372839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid recurrence of hyperparathyroidism from both nodularly hyperplastic autograft at forearm and residual tissues at neck after parathyroidectomy in a hemodialysis patient with calciphylaxis.
    Yeh CT; Lin YP; Yang WC; Yang AH; Lai MY; Lin CC
    Am J Med Sci; 2006 May; 331(5):284-7. PubMed ID: 16702801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume.
    Douthat WG; Orozco SE; de Arteaga J; Massari PU
    Kidney Int Suppl; 2003 Jun; (85):S101-4. PubMed ID: 12753277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism.
    Matsuoka S; Tominaga Y; Sato T; Uno N; Hiramitu T; Goto N; Nagasaka T; Uchida K
    Ther Apher Dial; 2008 Oct; 12(5):391-5. PubMed ID: 18937723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ultrasonography-guided therapeutic procedures in the neck region].
    Brzac HT
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():21-7. PubMed ID: 20235370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary hyperparathyroidism in chronic renal failure. Pathophysiology and treatment.
    Hanley DA; Sherwood LM
    Med Clin North Am; 1978 Nov; 62(6):1319-39. PubMed ID: 368449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
    Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
    Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
    Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell biology of parathyroid hyperplasia in uremia.
    Fukagawa M
    Am J Med Sci; 1999 Jun; 317(6):377-82. PubMed ID: 10372837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism--should it be abandoned?
    Korzets Z; Magen H; Kraus L; Bernheim J; Bernheim J
    Nephrol Dial Transplant; 1987; 2(5):341-6. PubMed ID: 2827062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperparathyroidism--new aspects].
    Kruse A; Beige J
    Ther Umsch; 2007 May; 64(5):265-9. PubMed ID: 17685085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question.
    Vulpio C; Bossola M
    Ther Apher Dial; 2018 Feb; 22(1):11-21. PubMed ID: 28980761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.